L Klareskog Selected Research

L Klareskog Research Topics

Disease

49	Rheumatoid Arthritis 01/2018 - 01/2000
20	Necrosis 01/2011 - 06/2000
12	Arthritis (Polyarthritis) 01/2017 - 05/2000
8	Inflammation (Inflammations) 03/2014 - 06/2000
6	Experimental Arthritis 01/2017 - 01/2000
5	Lymphoma (Lymphomas) 01/2018 - 10/2005
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2008 - 08/2000
5	Rheumatic Diseases (Rheumatism) 11/2005 - 06/2000
4	Neoplasms (Cancer) 08/2009 - 10/2005
2	Pain (Aches) 01/2011 - 11/2005
2	Infections 08/2009 - 12/2000
2	Dermatomyositis (Dermatopolymyositis) 10/2001 - 05/2000
2	Human Influenza (Influenza) 02/2001 - 01/2000
2	Mixed Connective Tissue Disease (MCTD) 01/2001 - 05/2000
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Osteophyte 01/2017
1	Osteoarthritis 01/2017
1	Congenital heart block 06/2014
1	Genetic Risk Score 03/2014
1	Ankylosing Spondylitis 09/2006
1	Giant Cell Arteritis (Horton Disease) 12/2005
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 12/2005
1	Skin Neoplasms (Skin Cancer) 10/2005
1	Colorectal Neoplasms (Colorectal Cancer) 10/2005
1	Melanoma (Melanoma, Malignant) 10/2005
1	Body Weight (Weight, Body) 04/2004
1	Nephritis 01/2004
1	Lupus Nephritis 01/2004
1	Atrophy 11/2002

Drug/Important Bio-Agent (IBA)

12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 06/2000
9	Biological ProductsIBA 08/2011 - 06/2000
9	Etanercept (Enbrel)FDA Link 03/2011 - 05/2002
8	CytokinesIBA 03/2005 - 05/2000
7	AntibodiesIBA 01/2018 - 01/2000
6	AutoantibodiesIBA 01/2018 - 05/2000
6	Anti-Citrullinated Protein AntibodiesIBA 01/2018 - 05/2009
6	Antirheumatic Agents (DMARD)IBA 03/2011 - 03/2001
5	Tumor Necrosis Factor InhibitorsIBA 01/2011 - 10/2005
5	Methotrexate (Mexate)FDA LinkGeneric 06/2009 - 08/2005
5	AntigensIBA 05/2009 - 01/2000
4	Pharmaceutical PreparationsIBA 08/2009 - 05/2000
4	Proteins (Proteins, Gene)FDA Link 09/2006 - 02/2001
4	Interleukin-10 (Interleukin 10)IBA 01/2002 - 08/2000
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2005
3	cyclic citrullinated peptideIBA 01/2018 - 10/2008
3	Collagen Type II (Type II Collagen)IBA 01/2017 - 01/2000
3	Peptides (Polypeptides)IBA 03/2015 - 12/2005
3	EpitopesIBA 05/2009 - 10/2008
3	Rituximab (Mabthera)FDA Link 03/2008 - 01/2004
3	TEMPOIBA 12/2007 - 08/2005
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2005 - 05/2000
3	Infliximab (Remicade)FDA Link 09/2004 - 12/2003
2	Immunoglobulin A (IgA)IBA 01/2018 - 04/2000
2	Immunoglobulin G (IgG)IBA 01/2018 - 05/2000
2	Immunoglobulin M (IgM)IBA 01/2018 - 03/2014
2	Hyaluronic Acid (Hyaluronan)IBA 01/2017 - 09/2002
2	HLA-DRB1 Chains (HLA DRB1)IBA 05/2009 - 02/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2008 - 01/2004
2	Prednisolone (Predate)FDA LinkGeneric 09/2007 - 01/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2005 - 04/2004
2	Fibrinogen (Factor I)FDA Link 04/2004 - 09/2002
2	Cartilage Oligomeric Matrix ProteinIBA 04/2004 - 09/2002
2	Interleukin-6 (Interleukin 6)IBA 10/2002 - 06/2000
2	Interferon-gamma (Interferon, gamma)IBA 04/2001 - 01/2000
2	Tuberculin (PPD)IBA 02/2001 - 01/2000
2	AutoantigensIBA 02/2001 - 01/2000
2	Interleukin-1alpha (Interleukin 1 alpha)IBA 11/2000 - 06/2000
1	gamma-glutamyl 4-phenylene diamine mustardIBA 01/2021
1	Cyclic PeptidesIBA 01/2017
1	pristane (pristan)IBA 01/2017
1	brassIBA 03/2014
1	Rheumatoid FactorIBA 03/2014
1	Serotonin ReceptorsIBA 03/2013
1	C-Reactive ProteinIBA 01/2011
1	golimumab FDA Link 06/2009
1	HLA-DR Antigens (HLA-DR)IBA 10/2008
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2008
1	LigandsIBA 07/2008
1	QuinoxalinesIBA 04/2008
1	9- chloro- 2,3- dimethyl- 6- (N,N- dimetylamino- 2- oxoethyl)- 6H- indolo(2,3- b)quinoxalineIBA 04/2008
1	GlucocorticoidsIBA 09/2007
1	ORALIT (ORS)IBA 09/2006
1	Anti-Idiotypic AntibodiesIBA 12/2005
1	SteroidsIBA 12/2005
1	amsonic acid (DAS)IBA 11/2005
1	SmokeIBA 10/2005
1	Adalimumab (Humira)FDA Link 09/2005
1	Silicon Dioxide (Silica)FDA LinkGeneric 04/2005
1	semapimodIBA 03/2005
1	Anticardiolipin AntibodiesIBA 09/2004
1	A-factor (Streptomyces)IBA 07/2004
1	Prostaglandins EIBA 06/2004
1	Prostaglandin-E SynthasesIBA 06/2004
1	Betamethasone (Celestone)FDA Link 04/2004
1	Monoclonal AntibodiesIBA 01/2004
1	Genetic Markers (Genetic Marker)IBA 06/2003

Therapy/Procedure

11	Therapeutics 08/2011 - 07/2000
2	Aftercare (After-Treatment) 10/2005 - 02/2001
1	Intra-Articular Injections 01/2017
1	Subcutaneous Injections 06/2009